RNS Number : 7586E
McBride PLC
09 July 2021
 

9 July 2021

 

McBride plc

 

Directorate change

 

McBride plc ("McBride" or the "Company") announces the appointment of Alastair Murray as a Non-Executive Director with effect from 2 August 2021.

 

Neil Harrington, Chair of the Audit Committee will be stepping down from the Board at the 2021 annual general meeting ("AGM"). As part of the Company's succession plans, it has been agreed that Alastair will be appointed as Chair of the Audit Committee immediately following the AGM. His appointment to Chair of the Audit Committee will be subject to his appointment as a director at the AGM.

 

Alastair has recent and relevant financial experience across a number of listed companies, including Premier Foods plc, Dairy Crest plc and The Body Shop International plc. As well as a background in Finance, Alastair has significant experience in corporate strategy, restructuring and M&A.

 

Alastair is an independent member of the Department for Education.  He currently holds no other directorships, however until September 2019 he was a director and Chief Financial Officer of Premier Foods plc.

 

Alastair will become a member of the Nomination, Remuneration and Audit Committees.

 

Jeff Nodland, Chairman of McBride, said: "Alastair brings valuable experience from customer-focused businesses including The Body Shop and Premier Foods. This, combined with his strong financial experience makes him an excellent addition to the Board. We are delighted to welcome Alastair to McBride."

 

McBride has been notified that there are no further details to be disclosed in respect of Alastair Murray pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority.

 

 

McBride plc

 

Jeff Nodland, Chairman

0161 203 7570

Chris Smith, CEO

 

 

 

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1017

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANXNEDFFEEA